Charles River Laboratories

Charles River Laboratories is a leading Contract Research Organization (CRO) dedicated to improving global health by supporting pharmaceutical, biotechnology, and medical device companies in developing life-saving medicines and therapies.

Charles River Laboratories is a global Contract Research Organization (CRO) committed to "creating healthier lives." They provide critical research support to pharmaceutical, biotechnology, and medical device companies worldwide, collaborating with universities, research institutions, and government organizations. With decades of experience, Charles River offers a comprehensive portfolio of services, including research models, drug discovery and development support, safety assessment, and biologics testing. Their expertise helps clients expedite preclinical drug development, ensure product safety and quality, and bring novel therapies to market. As a leader in research models, they supply high-quality research animals and specialized models for basic research and discovery. Their integrated portfolio, backed by hundreds of scientists, employs advanced technology for chemistry, biology, and pharmacology services, supporting clients from early hit identification through investigational new drug (IND) applications. They also offer robust safety assessment services and regulatory guidance, conducting approximately 120 IND programs annually. Furthermore, Charles River provides extensive endotoxin testing, microbial detection, and identification solutions designed to meet industry needs and regulatory requirements. Their Biologics group, with over 50 years of experience, offers a wide range of services to address complex projects for biotechnology and pharmaceutical companies, supporting over 20,000 biologic testing reports and 200 licensed products each year.

About

**Who they are**
Charles River Laboratories is a leading Contract Research Organization (CRO) dedicated to improving global health by supporting pharmaceutical, biotechnology, and medical device companies in developing life-saving medicines and therapies.

**Expertise & scope**
* Supports the development of life-saving medicines and therapies.
* Focuses on services for pharmaceutical, biotechnology, and medical device companies.

**Reputation / proof points**
* Established as a leading Contract Research Organization (CRO).

Additional information

Charles River Laboratories operates as a Contract Research Organization (CRO), assisting clients in the pharmaceutical, biotechnology, and medical device sectors. Their primary focus is on supporting the development of new medicines and therapies to enhance global health. Buyers engaging with Charles River Laboratories can expect a partner dedicated to the rigorous testing and development phases required for bringing medical innovations to market.

Key Highlights

  • Leading Contract Research Organization (CRO) supporting life sciences. Source
    “Charles River Laboratories is a leading Contract Research Organization (CRO) dedicated to improving global health by supporting pharmaceutical, biotechnology, and medical device companies in developing life-saving medicines and therapies.”

Certifications & Trust Signals

  • Dedicated to improving global health. Source
    “dedicated to improving global health by supporting pharmaceutical, biotechnology, and medical device companies”

Buyer Snapshot

Best for
  • Pharmaceutical companies
  • Biotechnology companies
  • Medical device companies
How engagement typically works
  • Collaborative development support
  • Research and testing services
Typical deliverables
  • Support for drug development
  • Therapy development assistance
  • Medical device testing
Good to know
  • Best when seeking a CRO for life-saving medicine and therapy development.
HQ: US
Languages: English
Claim status: Listed

Services & Capabilities

Biocompatibility Testing (ISO 10993 Program)

Industries: Medical Devices
Pricing model: Custom pricing
Iso10993 Standards Supported: ISO 10993-1, ISO 10993-5, ISO 10993-10, ISO 10993-11
Test Types Offered: Cytotoxicity, Sensitization, Irritation, Systemic toxicity, Genotoxicity, Implantation, Hemocompatibility, Pyrogenicity, Biodegradation
Glp Compliant: Yes
Has In House Toxicology: Yes
Toxicology Capabilities: Comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to investigational new drugs (IND). Expedite their preclinical drug development with exceptional, comprehensive safety assessment services, state-of-the-art facilities, and expert regulatory guidance. Approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities each year. Provide a comprehensive portfolio of endotoxin testing, microbial detection, and microbial identification products and services. Biologics group provides a breadth of services that can address challenging projects for biotechnology and pharmaceutical companies worldwide.
Contact Types Supported: Surface contact, External communicating, Implant
Duration Types Supported: Limited (< 24h), Prolonged (24h - 30d), Permanent (> 30d)
Nda Support: Yes
Lead Time Band: Start in 4-8 weeks
Quote SLA: 3-5 business days
Sample Return Policy: Both options
Minimum Project Size: $50k+

Additional biocompatibility_testing Details

Iso10993 Standards Supported
ISO 10993
Test Types Offered
Biocompatibility testing
Lead Time Band
Start in 4-8 weeks
Quote SLA
3-5 business days
Sample Return Policy
Dispose
Minimum Project Size
$50k+
Pricing Model
Custom
Request quotes
Cruxi - Regulatory Compliance Services